Blood test may forecast heart risks in shock patients
NCT ID NCT07507110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 264 patients who had a heart attack complicated by cardiogenic shock. Researchers examined whether the ratio of red blood cell distribution width to albumin (RAR) in the blood could predict major heart problems like death, another heart attack, or stroke during the hospital stay. The goal was to see if this simple blood marker helps identify high-risk patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuzhou Central Hospital
Xuzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a temporary heart pump save more lives in cardiogenic shock?
- Can a Community-Based rehab program boost heart recovery after a first attack?
- AI on a simple ECG: a new way to gauge heart attack severity?
- Can a diabetes drug shield the heart during a heart attack procedure?
- Smartphone apps and wearables could transform heart recovery
- Could aging clues in the blood predict heart attack recovery?